tirzepatide med 10mg/mL FDA says shortage of GLP-1

Preclinical research provides additional support

Common experiences at 1.0 mg: Consistent weekly weight loss of 0.5 to 1.5 pounds Significant reduction in hunger between meals Possible intermittent nausea, usually manageable and less intense than at 0.5 mg Increased fullness after smaller portions Some people develop mild acid reflux at this dose If the B12 component of your compounded formulation is going to show its value, this is when it starts mattering

PlexusDx emphasizes precision wellness: knowing your individual clearance factorskidney function, liver metabolism, and genetic predispositionscan support a more personalized conversation with your provider about expected duration of action and dose timing

Credit: Courtesy of Mindy Kaling/Instagram 2023 Kaling documented her adventures during a trip to India

They discuss a challenging case of RV failure & shock after placement of an AV graft

The overall response rate for Rybrevant plus chemo was 53% compared to 29% with chemo alone